Dr. Hudis Discusses Obesity as a Modifiable Risk Factor

Video

In Partnership With:

Clifford A. Hudis, MD, ASCO President-Elect and chief of the Breast Cancer Medicine Service and attending physician at Memorial Sloan-Kettering Cancer Center, discusses obesity as a modifiable risk factor for cancer.

Clifford A. Hudis, MD, ASCO President-Elect and chief of the Breast Cancer Medicine Service and attending physician at Memorial Sloan-Kettering Cancer Center, discusses obesity as a modifiable risk factor for cancer.

As president-elect, Hudis says that ASCO will begin to tackle the growing problem of obesity and its relationship to several common tumors: breast, high-grade prostate, colon, non-Hodgkin lymphoma, and others. There is a substantial amount of evidence that obesity is associated with higher rates of these tumors and worse outcomes.

Hudis says that ASCO has the opportunity to explore the science behind this issue and translate it into action. The theme for his term as president relates to this: the obligation to help society confront obesity as a modifiable risk factor. It is now projected in the U.S. that obesity will replace tobacco as the leading modifiable risk factor for these cancers.

Related Videos
Jeremy M. Pantin, MD, clinical director, Adult Transplant and Cellular Therapy Program, TriStar Centennial Medical Center, bone marrow transplant physician, Sarah Cannon Research Institute
Maria Hafez, MD, assistant professor, breast and sarcoma medical oncologist, director, Clinical Breast Cancer Research, Sidney Kimmel Medical College, Thomas Jefferson University
Zeynep Eroglu, MD
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Akriti Jain, MD
Raj Singh, MD
Gottfried Konecny, MD
Karim Chamie, MD, associate professor, urology, the University of California, Los Angeles
Mike Lattanzi, MD, medical oncologist, Texas Oncology
Ramez N. Eskander, MD